These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22619394)

  • 1. The effectiveness of substance use measures in the detection of full and partial denial of drug use.
    Wooley CN; Rogers R; Fiduccia CE; Kelsey K
    Assessment; 2013 Dec; 20(6):670-80. PubMed ID: 22619394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using brief self-reports and clinician scales to screen for substance use disorders in psychotic patients.
    Møller T; Linaker OM
    Nord J Psychiatry; 2010 Apr; 64(2):130-5. PubMed ID: 19883188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinician-rated versus self-rated screening for bipolar disorder among inpatients with mood symptoms and substance misuse.
    Goldberg JF; Garakani A; Ackerman SH
    J Clin Psychiatry; 2012 Dec; 73(12):1525-30. PubMed ID: 23290325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site.
    Newcombe DA; Humeniuk RE; Ali R
    Drug Alcohol Rev; 2005 May; 24(3):217-26. PubMed ID: 16096125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association between substance abuse problems and antisocial tendencies in male juvenile delinquents: A study using the Psychopathy Checklist, Youth Version].
    Matsumoto T; Okada T; Chiba Y; Ando K; Yoshikawa K; Wada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Feb; 41(1):59-71. PubMed ID: 16619849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does subtle screening for substance abuse work? A review of the Substance Abuse Subtle Screening Inventory (SASSI).
    Feldstein SW; Miller WR
    Addiction; 2007 Jan; 102(1):41-50. PubMed ID: 17207122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in the validity of the substance abuse subtle screening inventory--3 (SASSI-3) with a criminal justice population.
    Pérez DM; Wish ED
    Int J Offender Ther Comp Criminol; 2011 May; 55(3):476-91. PubMed ID: 20228318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test.
    Yudko E; Lozhkina O; Fouts A
    J Subst Abuse Treat; 2007 Mar; 32(2):189-98. PubMed ID: 17306727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopathy and substance use in adolescent male offenders.
    Mailloux DL; Forth AE; Kroner DG
    Psychol Rep; 1997 Oct; 81(2):529-30. PubMed ID: 9354106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of the MacAndrew Alcoholism Scale in detecting substance abuse and antisocial personality.
    Wolf AW; Schubert DS; Patterson M; Grande T; Pendleton L
    J Pers Assess; 1990; 54(3-4):747-55. PubMed ID: 2348354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective screening of substance dependence: the advantages of directness.
    Svanum S; McGrew J
    Addict Behav; 1995; 20(2):205-13. PubMed ID: 7484314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric properties of the Drug Use Disorders Identification Test (DUDIT) with substance abusers in outpatient and residential treatment.
    Voluse AC; Gioia CJ; Sobell LC; Dum M; Sobell MB; Simco ER
    Addict Behav; 2012 Jan; 37(1):36-41. PubMed ID: 21937169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Alcohol Use Disorders Identification Test and the Drug Use Disorders Identification Test in a Swedish sample of suspected offenders with signs of mental health problems: results from the Mental Disorder, Substance Abuse and Crime study.
    Durbeej N; Berman AH; Gumpert CH; Palmstierna T; Kristiansson M; Alm C
    J Subst Abuse Treat; 2010 Dec; 39(4):364-77. PubMed ID: 20822878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Japanese version of Substance Abuse Subtle Screening Inventory and its psychometric assessment.
    Kikuchi A; Wada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2000 Dec; 35(6):388-401. PubMed ID: 11197873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey.
    Simmons LA; Havens JR
    J Affect Disord; 2007 Apr; 99(1-3):265-71. PubMed ID: 16978706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for substance abuse in individuals with traumatic brain injury.
    Ashman TA; Schwartz ME; Cantor JB; Hibbard MR; Gordon WA
    Brain Inj; 2004 Feb; 18(2):191-202. PubMed ID: 14660230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New measures for assessing alcohol and drug abuse with the MMPI-2: The APS and AAS.
    Weed NC; Butcher JN; McKenna T; Ben-Porath YS
    J Pers Assess; 1992 Apr; 58(2):389-404. PubMed ID: 1315859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the SCID in substance abuse patients.
    Kranzler HR; Kadden RM; Babor TF; Tennen H; Rounsaville BJ
    Addiction; 1996 Jun; 91(6):859-68. PubMed ID: 8696248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of comorbid alcohol and substance abuse in depressed adolescents.
    King CA; Ghaziuddin N; McGovern L; Brand E; Hill E; Naylor M
    J Am Acad Child Adolesc Psychiatry; 1996 Jun; 35(6):743-51. PubMed ID: 8682755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential use of Internet-based screening for anxiety disorders: a pilot study.
    Van Ameringen M; Mancini C; Simpson W; Patterson B
    Depress Anxiety; 2010 Nov; 27(11):1006-10. PubMed ID: 20721902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.